Aurora Cannabis (TSE:ACB) First Quarter 2025 Results
Key Financial Results
- Revenue: CA$83.4m (up 12% from 1Q 2024).
- Net income: CA$6.22m (up from CA$18.8m loss in 1Q 2024).
- Profit margin: 7.5% (up from net loss in 1Q 2024).
- EPS: CA$0.12 (up from CA$0.53 loss in 1Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Aurora Cannabis Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 7.6%. Earnings per share (EPS) also surpassed analyst estimates.
Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company’s shares are up 7.8% from a week ago.
Risk Analysis
We don’t want to rain on the parade too much, but we did also find 2 warning signs…
